{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:36:59Z","timestamp":1773693419745,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":238,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012360","name":"Heart of England NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Reports"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.ebr.2020.100389","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T11:39:54Z","timestamp":1598873994000},"page":"100389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Moyamoya and progressive myoclonic epilepsy secondary to CLN6 bi-allelic mutations \u2013 A previously unreported association"],"prefix":"10.1016","volume":"14","author":[{"given":"Jamie","family":"Talbot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clinda","family":"Puvirajasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay M.","family":"Sisodiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fergus","family":"Rugg-Gunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebr.2020.100389_bb0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1474-4422(05)70043-0","article-title":"Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects","volume":"4","author":"Shahwan","year":"2005","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ebr.2020.100389_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnen\/62.1.1","article-title":"The neuronal ceroid-lipofuscinoses","volume":"62","author":"Haltia","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"10.1016\/j.ebr.2020.100389_bb0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bbadis.2006.07.001","article-title":"Diagnosis of the neuronal ceroid lipofuscinoses: an update","volume":"1762","author":"Williams","year":"2006","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"8","key":"10.1016\/j.ebr.2020.100389_bb0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s11910-013-0366-z","article-title":"Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum","volume":"13","author":"Cotman","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"10.1016\/j.ebr.2020.100389_bb0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1212\/WNL.0000000000002943","article-title":"Diagnosis and misdiagnosis of adult neuronal ceroid lipofuscinosis (Kufs disease)","volume":"87","author":"Berkovic","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebr.2020.100389_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/brain\/awy297","article-title":"Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features","volume":"142","author":"Berkovic","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ebr.2020.100389_bb0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.0000000000001784","article-title":"Electroclinical spectrum of the neuronal ceroid lipofuscinoses associated with CLN6 mutations","volume":"85","author":"Canafoglia","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ebr.2020.100389_bb0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1684\/epd.2017.0911","article-title":"Long-term follow-up of two siblings with adult-onset neuronal ceroid lipofuscinosis, Kufs type A","volume":"19","author":"\u00d6zkara","year":"2017","journal-title":"Epileptic Disord"},{"issue":"6","key":"10.1016\/j.ebr.2020.100389_bb0045","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.008","article-title":"Coexisting diseases of moyamoya vasculopathy","volume":"23","author":"Wei","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.ebr.2020.100389_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2007-973688","article-title":"Moyamoya disease in a child with glycogen storage disease type Ia","volume":"28","author":"Gouti\u00e8res","year":"1997","journal-title":"Neuropediatrics"},{"issue":"4","key":"10.1016\/j.ebr.2020.100389_bb0055","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1017\/S0317167100018618","article-title":"Moyamoya syndrome associated with mucolipidosis-II","volume":"41","author":"de Guzman","year":"2014","journal-title":"Can J Neurol Sci"},{"issue":"11","key":"10.1016\/j.ebr.2020.100389_bb0060","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.bbadis.2013.01.019","article-title":"Cell biology and function of neuronal ceroid lipofuscinosis-related proteins","volume":"183","author":"Kollmann","year":"2013","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"10.1016\/j.ebr.2020.100389_bb0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fnins.2015.00417","article-title":"Neuroinflammatory paradigms in lysosomal storage diseases","volume":"9","author":"Bosch","year":"2015","journal-title":"Front Neurosci"},{"issue":"37","key":"10.1016\/j.ebr.2020.100389_bb0070","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.2174\/1381612823666170809114654","article-title":"Update on pharmacological treatment of progressive myoclonus epilepsies","volume":"23","author":"Ferlazzo","year":"2017","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.ebr.2020.100389_bb0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5853\/jos.2015.01739","article-title":"Moyamoya disease: treatment and outcomes","volume":"18","author":"Kim","year":"2016","journal-title":"J Stroke"}],"container-title":["Epilepsy & Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258998642030037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258998642030037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:07:58Z","timestamp":1762906078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258998642030037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":15,"alternative-id":["S258998642030037X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2020.100389","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moyamoya and progressive myoclonic epilepsy secondary to CLN6 bi-allelic mutations \u2013 A previously unreported association","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2020.100389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100389"}}